The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Single-Chamber Prefilled Syringes Market Be By 2030 Compared To Its 2026 Market Size?
The single-chamber prefilled syringes market size has experienced rapid growth in recent years. This market is set to expand from $11.97 billion in 2025 to $13.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.4%. The expansion observed in previous periods can be attributed to developments such as the growth in injectable drug formulations, a rise in vaccination programs, the broadening of biologics manufacturing, a heightened focus on patient safety standards, and the accessibility of advanced packaging materials.
The single-chamber prefilled syringes market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a value of $25.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.7%. This projected increase can be attributed to several factors during the forecast period, including a heightened demand for self-administered injectable medications, the expanding pipeline for biologics, an increase in drug administration at home, a growing emphasis on sustainable packaging, and the broader adoption of prefilled syringes in developing markets. Key trends identified for the forecast period encompass the wider embrace of prefilled drug delivery systems, a surge in demand for injectable formats that are ready-to-use, the increasing utilization of plastic-based materials for syringes, the expanding scope of applications for vaccine and biologic packaging, and a heightened emphasis on precise dosing and ensuring patient safety.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Single-Chamber Prefilled Syringes Market Development?
The increasing incidence of chronic conditions such as diabetes and cancer is significantly contributing to the expansion of the single-chamber prefilled syringe market. Patients suffering from diabetes who require insulin therapy when conventional medications fail to regulate their blood glucose levels utilize these syringes. The rise in the prevalence of chronic diseases like diabetes and cancer is largely due to increasingly sedentary lifestyles, which disrupt metabolic balance and diminish long-term physiological resilience, ultimately elevating the risk of chronic illness. Single-chamber prefilled syringes play a crucial role in managing chronic diseases such as diabetes and cancer by facilitating the rapid, accurate, and convenient delivery of injectable therapies, thereby improving treatment adherence and reducing dosing errors during long-term care. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency responsible for international public health, projected that by 2050, there will be over 35 million new cancer cases, representing a 77% increase from the estimated 20 million cases in 2022. This growing prevalence of chronic diseases such as diabetes and cancer is thus a primary driver for the single-chamber prefilled syringe market.
What Are The Key Segment Divisions In The Single-Chamber Prefilled Syringes Market Segment Structure?
The single-chamber prefilled syringes market covered in this report is segmented –
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers And Specialty Clinics, Home Healthcare And Self-Administration
Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
What Trends Are Transforming The Single-Chamber Prefilled Syringes Market?
Leading companies in the Single-Chamber Prefilled Syringes market are concentrating on developing innovative polymer-based single-dose prefilled syringe systems. This effort aims to address the increasing demand for scalable, cost-effective, and safe injectable delivery formats, driven by the expanding use of biologics and the trend towards home self-administration. Polymer prefilled syringes are constructed using materials like cyclic-olefin polymer (COP) or cyclic-olefin copolymer (COC), which provide excellent drug stability and inertness, coupled with a reduced risk of breakage compared to traditional glass syringes. For instance, in January 2023, Sharps Technology, Inc., a U.S.-based medical device and pharmaceutical-packaging company, announced its intention to introduce next-generation specialty polymer prefillable syringe systems, manufactured in cooperation with Nephron Pharmaceuticals, using COP and COC materials. These advanced syringes are designed to decrease contamination, minimize dead space, and eliminate breakage risk, while maintaining compatibility with existing fill-finish lines. They are also free from silicon to reduce aggregation risk, thereby making them safer and more reliable. (Source: Sharps Technology press release.)
Which Organizations Are Engaged In The Single-Chamber Prefilled Syringes Market?
Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
Get The Full Single-Chamber Prefilled Syringes Market Report:
Where Is The Single-Chamber Prefilled Syringes Market Most Concentrated Geographically?
North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-chamber prefilled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Single-Chamber Prefilled Syringes Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Single-Chamber Prefilled Syringes Market 2026, By The Business Research Company
Pre Filled Syringes Market Report 2026
https://www.thebusinessresearchcompany.com/report/pre-filled-syringes-global-market-report
Disposable Syringes Market Report 2026
https://www.thebusinessresearchcompany.com/report/disposable-syringes-global-market-report
Syringe Trays Market Report 2026
https://www.thebusinessresearchcompany.com/report/syringe-trays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model